Sign in

CIK 0001610820 · Non-accelerated filer<br>Smaller reporting company

BriaCell Therapeutics Corp.

Sign in to watch
Ticker
BCTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jul 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 921-1810
Business address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, British Columbia, Canada, V7T 2X1
Former names
Ansell Capital Corp.

Securities

  • BCTX Common Shares Nasdaq
  • BCTXL Warrants Nasdaq
  • BCTXZ Warrant Nasdaq
  1. 4 Open-market buy Director bought 902,935 shares at $2.22 ($2,000,001)
  2. 4 Open-market buy Chairman bought 28,000 shares at $4.58 ($128,240)
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Director bought 22,000 shares at $5.35 ($117,700)
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership

Page 1 of 1 · 14 filings